Mony Chenda Morisse - Concepedia

Author

Mony Chenda Morisse

Centre Hospitalier Universitaire Amiens-Picardie ORCID

Also Known As

M Morisse, M. C. Morisse, MONY CHENDA MORISSE, Mony Chenda Morisse, Mony Chenda Morisse

Publications

244

Citations

H-Index

Concepts

All Affiliations

Centre Hospitalier Universitaire Amiens-Picardie Inserm Sorbonne Université Assistance Publique – Hôpitaux de Paris Centre National de la Recherche Scientifique

About

Mony Chenda Morisse is an author at Centre Hospitalier Universitaire Amiens-Picardie specializing in medicine, cancer therapeutics, and glioma.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	125
2	Cell Biology	2	2	97
3	Immunology	2	2	53
4	Health Sciences	1	1	15
5	Natural Sciences	1	1	59

Mony Chenda Morisse

Publications

164

Citations

H-Index

Page 1

	Year	Citations
Adaptation to DNA damage checkpoint in senescent telomerase-negative cells promotes genome instability Héloïse Coutelier, Zhou Xu, Mony Chenda Morisse, Genes & Development Prolonged Checkpoint ArrestsDna DamageGeneticsMolecular BiologyCell Cycle	2018	59
ERK1/2 signaling regulates the immune microenvironment and macrophage recruitment in glioblastoma Claire Lailler, Christophe Louandre, Mony Chenda Morisse, Bioscience Reports Immune MicroenvironmentImmunologyBiological MicroenvironmentsCancer BiologyGlioma	2019	38
Squamous Cell Carcinoma Antigen-encoding Genes SERPINB3/B4 as Potentially Useful Markers for the Stratification of HNSCC Tumours Zuzana Saidak, Mony Chenda Morisse, Denis Chatelain, Anticancer Research	2018	18
Efficacy and safety of tisagenlecleucel (Tisa-cel) in adult patients (Pts) with relapsed/refractory follicular lymphoma (r/r FL): Primary analysis of the phase 2 Elara trial. Stephen J. Schuster, Michael Dickinson, Martin Dreyling, Journal of Clinical Oncology ImmunologyImmunotherapyOncologyComplete Response RateHematology	2021	15
Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study Mony Chenda Morisse, Nelly Étienne-Selloum, Diana Bello-Roufai, Journal of Neuro-Oncology Neuro-oncologyOncologyMulticentric Retrospective StudyLong-term SurvivalImmune Checkpoint Inhibitor	2019	13
Isatuximab-pomalidomide-dexamethasone <i>versus</i> pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis Paul G. Richardson, Aurore Perrot, Jesús F. San Miguel, Haematologica	2024	11
Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment Ilan Darmon, Mony Chenda Morisse, Alexandre Coutté, Journal of Cancer	2017	10

Page 1